Recently, the World Health Organization (WHO) has declared that Zika, a virus, which has been linked to birth defects and neurological complications, no longer constitutes an international emergency. However, it still remains a threat which calls for a long term efforts to address the issue through development of vaccines. Several ongoing clinical trials led by government and private pharmaceutical companies have shown a great promise in the treatment of Zika. Apart from these trials, there are also ongoing research on understanding the virus better, its transmission mode and future possibility of leveraging it in other disease treatments. This article provides an insight on these efforts and their findings.

Article Url: https://www.scitechnol.com/peer-review/recent-developments-on-conquering-zika-HDqt.php?article_id=7124

Journal of Pharmaceutics & Drug Delivery Research (IS0SN: 2325-9604) is a subscription based journal that provides a range of options to purchase our articles and also permits unlimited Internet Access to complete Journal content. Journal (JPDDR) promotes rigorous research that makes a significant contribution in advancing knowledge for Drug Delivery Research. Articles submitted by authors are evaluated by a group of peer review experts in the field and ensures that the published articles are of high quality, reflect solid scholarship in their fields, and that the information they contain is accurate and reliable. The journal is committed to serve its readers authors by adding the state of the art facilities to enhance the author’s scholarly visibility.

On the behalf of Editorial in Chief we are pleased to invite you for the submission of manuscript for the first issue of 2020 in month of March.

Articles can be submitted online or revert back to this mail id: drugres@peerjournal.org

Thanks & Regards,

Subhana Quadri
Journal Coordinator
Journal of Pharmaceutics and Drug Delivery
drugdelivary@peerreviewedjournal.org
Scitechnol
Whtasapp No: 44-20-386-84024